0001562180-22-006641.txt : 20220913
0001562180-22-006641.hdr.sgml : 20220913
20220913204540
ACCESSION NUMBER: 0001562180-22-006641
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210427
FILED AS OF DATE: 20220913
DATE AS OF CHANGE: 20220913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39634
FILM NUMBER: 221241891
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foghorn Therapeutics Inc.
CENTRAL INDEX KEY: 0001822462
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-586-3100
MAIL ADDRESS:
STREET 1: 500 TECHNOLOGY SQUARE
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
3/A
1
primarydocument.xml
PRIMARY DOCUMENT
X0206
3/A
2021-04-27
2021-04-29
0
0001822462
Foghorn Therapeutics Inc.
FHTX
0001197032
SMITH IAN F
500 TECHNOLOGY SQUARE
STE #700
CAMBRIDGE
MA
02139
true
false
false
false
Common Stock
72072.00
D
Stock Options (Right to buy)
10.38
2030-09-23
Common Stock
16216.00
D
Stock Options (Right to buy)
3.93
2030-06-03
Common Stock
8108.00
D
The option was granted pursuant to a consulting agreement effective September 1, 2020 and is fully vested.
The option was granted pursuant to a consulting agreement effective January 1, 2020 and is fully vested.
This Form 3/A is being filed solely to include the Reporting Person's Power of Attorney as Exhibit 24. The holdings reported on this form are being re-reported, as of the date of the original filing, solely for the purpose of filing Exhibit 24.
/s/ Michael LaCascia, Attorney-in-Fact for Ian F. Smith
2022-09-13
EX-24
2
smithex24.txt
POWER OF ATTORNEY- SMITH
LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Allan Reine,
Michael LaCascia and Tara Maduri, and each of them individually,
with full power of substitution, as the undersigned's true and
lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities
and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings
with the SEC of reports required by Section 16(a) of
the Securities Exchange Act of 1934, as amended, or any
rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the
undersigned's capacity as officer and/or director of
Foghorn Therapeutics Inc. (the "Company"), Forms 3, 4,
5 and any Schedules 13D or 13G in accordance with
Section 16(a) of the Securities Exchange Act of 1934,
as amended, and the rules thereunder;
(3) do and perform any and all acts for and on behalf of
the undersigned that may be necessary or desirable to
complete and execute any such Form 3, 4, or 5 or
Schedule 13D or 13G, complete and execute any amendment
or amendments thereto, and timely file such form with
the SEC and any stock exchange or similar authority;
and
(4) take any other action of any type whatsoever in
connection with the foregoing that, in the opinion of
each such attorney-in-fact, may be of benefit to, in
the best interest of, or legally required by, the
undersigned, it being understood that the documents
executed by each such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be
in such form and shall contain such terms and
conditions as each such attorney-in-fact may approve in
each such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact
full power and authority to do and perform any and every act and
thing whatsoever requisite, necessary, or proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution
or revocation, hereby ratifying and confirming all that each such
attorney-in-fact, or each such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted.
The undersigned acknowledges that each foregoing attorney-in-
fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any
of the undersigned's responsibilities to comply with Section 16
of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4,
5, and any Schedules 13D or 13G with respect to the undersigned's
holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing
delivered to each foregoing attorney-in-fact.
[Remainder of page intentionally left blank]
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 27th day of April, 2021.
/s/ Ian Smith
Name: Ian Smith